Request for Information on the Development of the Fiscal Year 2021-2025 Trans-NIH Strategic Plan for Sexual & Gender Minority Health Research, 68179-68180 [2019-26915]

Download as PDF Federal Register / Vol. 84, No. 240 / Friday, December 13, 2019 / Notices in place for 6 months after the conclusion on the workshop or Summit. Healthy Aging Workshops and Summit Opportunity A—Healthy Aging Regional Workshops will involve executing a single or series of financially self-sustaining workshops that convene aging and public health stakeholders to support regional action planning and dissemination of information on healthy aging, aging in place, and age-friendly public health systems. ODPHP plans to hold four workshops. Each workshop will be held in a city located in one of the designated HHS Regional pairs—Regions 3 & 4 (Atlanta), Regions 6 & 9 (Phoenix or Albuquerque), Regions 5 & 7 (Kansas City or Chicago), and Regions 8 & 10 (Denver). Opportunity B—2021 Healthy Aging Summit—The collaborative project will involve executing a single financially self-sustaining conference that supports research and information-sharing on health promotion and disease prevention research across the lifespan. This conference draws more than 600 stakeholders, every three years, to examine the state of the science and best practices in healthy aging through a social determinants of health lens. Past conference information can be found here: https://www.eventscribe.com/ 2018/ACPM-HAC/index.asp? launcher=1. jbell on DSKJLSW7X2PROD with NOTICES Eligibility for Co-Sponsorships To be eligible, a collaborating organization shall: (1) Have a demonstrated interest in, understanding of, and experience with managing the development and execution of engaging programs, activations and/or other activities related to disease prevention and health promotion; (2) participate substantively in the co-sponsored activity (not only logistical support) including helping plan the 2020 Healthy Aging Regional workshops and/or 2021 Healthy Aging Summit; (3) have an organizational or corporate mission that is aligned with the mission of ODPHP and HHS; and (4) sign a co-sponsorship agreement with ODPHP that will set forth the details of the Healthy Aging Regional Workshop and/or Summit, including the requirements that any registration fees raised should not exceed the collaborating organization’s costs, and fees collected by the cosponsor should be limited to the amount necessary to cover the co-sponsor’s event-related operating expenses. Cosponsors are solely responsible for collecting and handling any fees to cover their costs. VerDate Sep<11>2014 17:42 Dec 12, 2019 Jkt 250001 The co-sponsor will furnish the necessary personnel, materials, services, and facilities to administer its responsibility for the proposed Healthy Aging Regional Workshops and/or Summit. These duties will be determined and outlined in a cosponsorship agreement with ODPHP. This co-sponsorship agreement does not represent an endorsement by ODPHP of an individual co-sponsor’s policies, positions, or activities. Co-Sponsorship Proposal Each potential co-sponsor’s proposal shall contain a description of: (1) The entity or organization’s interest and goals in healthy aging; (2) Prior experience and current readiness to undertake the responsibilities for planning and organizing a Healthy Aging Regional workshop(s) and/or Summit; (3) Requester’s information: Name, professional qualifications and specific expertise of key personnel who would be available to work on the project; (4) The type of event(s), i.e., Workshop or 2021 Summit, that the entity is interested in co-sponsoring with ODPHP; (5) Facilities available for the event(s); (6) Description of financial management: Discussion of experience in developing a project budget and collecting and managing monies from organizations and individuals; (7) For the Healthy Aging Summit only: Proposed plan for managing Summit, including, but not limited to participant recruitment, call for abstracts distribution/review, ability to provide CEs, website development and/ or enhancement, cost of materials, and distribution of those items. Proposals should be no more than four (4) pages, 12 point font, double spaced. Dated: November 29, 2019. Donald Wright, Deputy Assistant Secretary for Health, Disease Prevention and Health Promotion. [FR Doc. 2019–26821 Filed 12–12–19; 8:45 am] BILLING CODE 4150–32–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Request for Information on the Development of the Fiscal Year 2021– 2025 Trans-NIH Strategic Plan for Sexual & Gender Minority Health Research AGENCY: National Institutes of Health, HHS. PO 00000 Frm 00080 Fmt 4703 Sfmt 4703 ACTION: 68179 Notice. Through this Request for Information (RFI), the Sexual & Gender Minority Research Office (SGMRO) in the Division of Program Coordination, Planning, and Strategic Initiatives (DPCPSI), Office of the Director (OD), National Institutes of Health (NIH), invites feedback from stakeholders throughout the scientific research community, clinical practice communities, patient and family advocates, scientific or professional organizations, federal partners, internal NIH stakeholders, and other interested constituents on the development of the fiscal years (FY) 2021–2025 Trans-NIH Strategic Plan for Sexual and Gender Minority Health Research. This plan will describe future directions in sexual and gender minority (SGM) health and research to optimize NIH’s research investments. DATES: The SGMRO’s Request for Information is open for public comment for a period of 6 weeks. Comments must be received on or before COB (5:00 p.m. ET) January 24, 2020 to ensure consideration. After the public comment period has closed, the comments received by SGMRO will be considered in a timely manner for the development of the FY 2021–2025 Trans-NIH Strategic Plan for SGM Health Research. ADDRESSES: Please see the supplementary information to view the draft scientific and operational goals. Comments are strongly encouraged to be submitted by email to SGMRO@nih.gov or by mail to: SGMRO, DPCPSI, NIH, 6555 Rock Spring Drive, Suite 220, Rm. 2SE31J, Bethesda, MD 20817. Please include strategic plan in the subject line. FOR FURTHER INFORMATION CONTACT: Karen Parker, Ph.D., MSW, Director, Sexual & Gender Minority Research Office (SGMRO), 6555 Rock Spring Drive, Suite 220, Rm 2SE31K, Bethesda, MD 20817, klparker@mail.nih.gov, 301– 451–2055. SUPPLEMENTARY INFORMATION: Background: ‘‘Sexual and gender minority’’ is an umbrella term that includes, but is not limited to, individuals who identify as lesbian, gay, bisexual, asexual, transgender, twospirit, queer, and/or intersex. Individuals with same-sex or -gender attractions or behaviors and those with a difference in sex development are also included. These populations also encompass those who do not selfidentify with one of these terms but whose sexual orientation, gender identity or expression, or reproductive development is characterized by nonSUMMARY: E:\FR\FM\13DEN1.SGM 13DEN1 jbell on DSKJLSW7X2PROD with NOTICES 68180 Federal Register / Vol. 84, No. 240 / Friday, December 13, 2019 / Notices binary constructs of sexual orientation, gender, and/or sex. The Sexual and Gender Minority Research Office (SGMRO) coordinates sexual and gender minority (SGM)related research and activities by working directly with the NIH Institutes, Centers, and Offices. The Office was officially established in September 2015 within the NIH Division of Program Coordination, Planning, and Strategic Initiatives (DPCPSI) in the Office of the Director. In accordance with the 21st Century Cures Act, NIH is required to regularly update their strategic plans. In 2015, the NIH launched the NIH FY 2016–2020 Strategic Plan to Advance Research on the Health and Well-being of Sexual and Gender Minorities. The current strategic plan has provided the NIH with a framework to improve the health of SGM populations through increased research and support of scientists conducting SGM-relevant research. In January 2019, SGMRO published a midcourse review of the current NIH SGM strategic plan that provided recommendations to support further progress on the goals described therein. To establish NIH priorities in SGM health research for the next five years, SGMRO requests input from SGM health, research, and related communities in refining the goals of the FY 2021–2025 strategic plan. Request for Comment on Draft Goals: The NIH is developing a strategic plan to advance SGM research over the next five years. The SGMRO invites input from stakeholders throughout the scientific research community, clinical practice communities, patient and family advocates, scientific or professional organizations, federal partners, internal NIH stakeholders, and other interested members of the public on the proposed framework. This input is a valuable component in developing the SGM research strategic plan, and the community’s time and consideration are appreciated. The populations considered under the SGM umbrella term are inclusive and captures all individuals and populations who do not self-identify with binary constructs of sexual orientation, gender, and/or sex. For the FY 2021–2025 strategic plan, the scientific goals will include a focus on specific populations on which the lack of research remains significant. Examples of such populations may include persons with differences in sex development (DSD), intersex, bisexual, transgender, gender nonconforming, persons who have detransitioned/desisted people, and SGM populations in Native communities. VerDate Sep<11>2014 17:42 Dec 12, 2019 Jkt 250001 In addition, overarching topics will be considered across all scientific research goal areas in order to help foster a deeper understanding of SGM health disparities. Topics to be considered include health equity, research across the life span, trauma-informed research, community and culturally grounded research, and strengths-based approaches. Scientific goal areas will also take into consideration intersectionality by recognizing overlapping and interconnected systems of oppression across different social categories and how they may compound health inequities. Examples of such categories may include ability status, age, race, ethnicity, incarceration status, veteran status, income level, and more. The NIH has identified four scientific research goal areas: • Clinical Research: Examples include outcomes related to various DSDs, and sexual reproduction and pregnancy outcomes • Social & Behavioral Research: Examples include the coming out process, healthy sexuality, interpersonal violence, mental health, substance use and abuse (opioids, tobacco use, other drugs), suicide risk and prevention, and stigma and discrimination • Chronic Diseases and Comorbidities Research: Examples include Alzheimer’s Disease and Related Dementias (ADRD), cancer, diabetes, heart disease, HIV/AIDS, and infectious diseases • Methods and Measures Research: Examples include culturally humble psychometrics, research on recruitment and sampling methods, particularly for most understudied SGM subgroups, and factors related to disclosure on surveys The NIH has also identified four operational goal areas: • Advance rigorous research on the health of SGM populations in both the extramural and intramural research communities • Expand SGM health research by fostering partnerships and collaborations with a strategic array of internal and external stakeholders • Foster a highly skilled and diverse workforce in the SGM health research • Encourage data collection related to SGM populations in research and in the biomedical research workforce The NIH seeks comments and/or suggestions from all interested parties on the proposed strategic plan goals. Responses to this RFI are voluntary. Do not include any proprietary, classified, confidential, trade secret, or sensitive information in your response. The responses will be reviewed by NIH staff, and individual feedback will not be provided to any responder. The PO 00000 Frm 00081 Fmt 4703 Sfmt 4703 Government will use the information submitted in response to this RFI at its discretion. The Government reserves the right to use any submitted information on public NIH websites; in reports; in summaries of the state of the science; in any possible resultant solicitation(s), grant(s), or cooperative agreement(s); or in the development of future funding opportunity announcements. This RFI is for information and planning purposes only and should not be construed as a solicitation for applications or proposals, or as an obligation in any way on the part of the United States Federal Government, the NIH, or individual NIH Institutes, Centers, and Offices to provide support for any ideas identified in response to it. The Federal Government will not pay for the preparation of any information submitted or for the Government’s use of such information. No basis for claims against the U.S. Government shall arise as a result of a response to this RFI or from the Government’s use of such information. Additionally, the Government cannot guarantee the confidentiality of the information provided. Dated: December 6, 2019. Lawrence A. Tabak, Principal Deputy Director, National Institutes of Health. [FR Doc. 2019–26915 Filed 12–12–19; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HOMELAND SECURITY U.S. Customs and Border Protection [1651–0098] Agency Information Collection Activities: NAFTA Regulations and Certificate of Origin U.S. Customs and Border Protection (CBP), Department of Homeland Security. ACTION: 60-Day notice and request for comments; extension of an existing collection of information. AGENCY: The Department of Homeland Security, U.S. Customs and Border Protection will be submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995 (PRA). The information collection is published in the Federal Register to obtain comments from the public and affected agencies. Comments are encouraged and must be SUMMARY: E:\FR\FM\13DEN1.SGM 13DEN1

Agencies

[Federal Register Volume 84, Number 240 (Friday, December 13, 2019)]
[Notices]
[Pages 68179-68180]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-26915]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Request for Information on the Development of the Fiscal Year 
2021-2025 Trans-NIH Strategic Plan for Sexual & Gender Minority Health 
Research

AGENCY: National Institutes of Health, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: Through this Request for Information (RFI), the Sexual & 
Gender Minority Research Office (SGMRO) in the Division of Program 
Coordination, Planning, and Strategic Initiatives (DPCPSI), Office of 
the Director (OD), National Institutes of Health (NIH), invites 
feedback from stakeholders throughout the scientific research 
community, clinical practice communities, patient and family advocates, 
scientific or professional organizations, federal partners, internal 
NIH stakeholders, and other interested constituents on the development 
of the fiscal years (FY) 2021-2025 Trans-NIH Strategic Plan for Sexual 
and Gender Minority Health Research. This plan will describe future 
directions in sexual and gender minority (SGM) health and research to 
optimize NIH's research investments.

DATES: The SGMRO's Request for Information is open for public comment 
for a period of 6 weeks. Comments must be received on or before COB 
(5:00 p.m. ET) January 24, 2020 to ensure consideration. After the 
public comment period has closed, the comments received by SGMRO will 
be considered in a timely manner for the development of the FY 2021-
2025 Trans-NIH Strategic Plan for SGM Health Research.

ADDRESSES: Please see the supplementary information to view the draft 
scientific and operational goals. Comments are strongly encouraged to 
be submitted by email to [email protected] or by mail to: SGMRO, DPCPSI, 
NIH, 6555 Rock Spring Drive, Suite 220, Rm. 2SE31J, Bethesda, MD 20817. 
Please include strategic plan in the subject line.

FOR FURTHER INFORMATION CONTACT: Karen Parker, Ph.D., MSW, Director, 
Sexual & Gender Minority Research Office (SGMRO), 6555 Rock Spring 
Drive, Suite 220, Rm 2SE31K, Bethesda, MD 20817, [email protected], 
301-451-2055.

SUPPLEMENTARY INFORMATION: 
    Background: ``Sexual and gender minority'' is an umbrella term that 
includes, but is not limited to, individuals who identify as lesbian, 
gay, bisexual, asexual, transgender, two-spirit, queer, and/or 
intersex. Individuals with same-sex or -gender attractions or behaviors 
and those with a difference in sex development are also included. These 
populations also encompass those who do not self-identify with one of 
these terms but whose sexual orientation, gender identity or 
expression, or reproductive development is characterized by non-

[[Page 68180]]

binary constructs of sexual orientation, gender, and/or sex.
    The Sexual and Gender Minority Research Office (SGMRO) coordinates 
sexual and gender minority (SGM)-related research and activities by 
working directly with the NIH Institutes, Centers, and Offices. The 
Office was officially established in September 2015 within the NIH 
Division of Program Coordination, Planning, and Strategic Initiatives 
(DPCPSI) in the Office of the Director.
    In accordance with the 21st Century Cures Act, NIH is required to 
regularly update their strategic plans. In 2015, the NIH launched the 
NIH FY 2016-2020 Strategic Plan to Advance Research on the Health and 
Well-being of Sexual and Gender Minorities. The current strategic plan 
has provided the NIH with a framework to improve the health of SGM 
populations through increased research and support of scientists 
conducting SGM-relevant research. In January 2019, SGMRO published a 
mid-course review of the current NIH SGM strategic plan that provided 
recommendations to support further progress on the goals described 
therein. To establish NIH priorities in SGM health research for the 
next five years, SGMRO requests input from SGM health, research, and 
related communities in refining the goals of the FY 2021-2025 strategic 
plan.
    Request for Comment on Draft Goals: The NIH is developing a 
strategic plan to advance SGM research over the next five years. The 
SGMRO invites input from stakeholders throughout the scientific 
research community, clinical practice communities, patient and family 
advocates, scientific or professional organizations, federal partners, 
internal NIH stakeholders, and other interested members of the public 
on the proposed framework. This input is a valuable component in 
developing the SGM research strategic plan, and the community's time 
and consideration are appreciated.
    The populations considered under the SGM umbrella term are 
inclusive and captures all individuals and populations who do not self-
identify with binary constructs of sexual orientation, gender, and/or 
sex. For the FY 2021-2025 strategic plan, the scientific goals will 
include a focus on specific populations on which the lack of research 
remains significant. Examples of such populations may include persons 
with differences in sex development (DSD), intersex, bisexual, 
transgender, gender nonconforming, persons who have detransitioned/
desisted people, and SGM populations in Native communities.
    In addition, overarching topics will be considered across all 
scientific research goal areas in order to help foster a deeper 
understanding of SGM health disparities. Topics to be considered 
include health equity, research across the life span, trauma-informed 
research, community and culturally grounded research, and strengths-
based approaches. Scientific goal areas will also take into 
consideration intersectionality by recognizing overlapping and 
interconnected systems of oppression across different social categories 
and how they may compound health inequities. Examples of such 
categories may include ability status, age, race, ethnicity, 
incarceration status, veteran status, income level, and more.
    The NIH has identified four scientific research goal areas:
     Clinical Research: Examples include outcomes related to 
various DSDs, and sexual reproduction and pregnancy outcomes
     Social & Behavioral Research: Examples include the coming 
out process, healthy sexuality, interpersonal violence, mental health, 
substance use and abuse (opioids, tobacco use, other drugs), suicide 
risk and prevention, and stigma and discrimination
     Chronic Diseases and Comorbidities Research: Examples 
include Alzheimer's Disease and Related Dementias (ADRD), cancer, 
diabetes, heart disease, HIV/AIDS, and infectious diseases
     Methods and Measures Research: Examples include culturally 
humble psychometrics, research on recruitment and sampling methods, 
particularly for most understudied SGM subgroups, and factors related 
to disclosure on surveys
    The NIH has also identified four operational goal areas:
     Advance rigorous research on the health of SGM populations 
in both the extramural and intramural research communities
     Expand SGM health research by fostering partnerships and 
collaborations with a strategic array of internal and external 
stakeholders
     Foster a highly skilled and diverse workforce in the SGM 
health research
     Encourage data collection related to SGM populations in 
research and in the biomedical research workforce
    The NIH seeks comments and/or suggestions from all interested 
parties on the proposed strategic plan goals.
    Responses to this RFI are voluntary. Do not include any 
proprietary, classified, confidential, trade secret, or sensitive 
information in your response. The responses will be reviewed by NIH 
staff, and individual feedback will not be provided to any responder. 
The Government will use the information submitted in response to this 
RFI at its discretion. The Government reserves the right to use any 
submitted information on public NIH websites; in reports; in summaries 
of the state of the science; in any possible resultant solicitation(s), 
grant(s), or cooperative agreement(s); or in the development of future 
funding opportunity announcements.
    This RFI is for information and planning purposes only and should 
not be construed as a solicitation for applications or proposals, or as 
an obligation in any way on the part of the United States Federal 
Government, the NIH, or individual NIH Institutes, Centers, and Offices 
to provide support for any ideas identified in response to it. The 
Federal Government will not pay for the preparation of any information 
submitted or for the Government's use of such information. No basis for 
claims against the U.S. Government shall arise as a result of a 
response to this RFI or from the Government's use of such information. 
Additionally, the Government cannot guarantee the confidentiality of 
the information provided.

    Dated: December 6, 2019.
Lawrence A. Tabak,
Principal Deputy Director, National Institutes of Health.
[FR Doc. 2019-26915 Filed 12-12-19; 8:45 am]
 BILLING CODE 4140-01-P